Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility
From MaRDI portal
(Redirected from Publication:2219787)
Recommendations
- The influence of anti-viral drug therapy on the evolution of HIV-1 pathogens
- Modeling within-host viral dynamics: the role of CTL immune responses in the evolution of drug resistance
- A within-host drug resistance model with continuous state-dependent viral strains
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects
Cites work
- scientific article; zbMATH DE number 1974540 (Why is no real title available?)
- scientific article; zbMATH DE number 2038872 (Why is no real title available?)
- A delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cells
- A model for treatment strategy in the chemotherapy of AIDS
- A model of HIV-1 pathogenesis that includes an intracellular delay
- An age-structured model of HIV infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells
- Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay
- Drug concentration heterogeneity facilitates the evolution of drug resistance
- Dynamics of HIV infection of CD4^ + T cells
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- HIV-1 infection and low steady state viral loads
- Mathematical Analysis of Age‐Structured HIV‐1 Dynamics with Combination Antiretroviral Therapy
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Mathematical analysis of delay differential equation models of HIV-1 infection
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- Optimal viral production
- Optimizing within-host viral fitness: infected cell lifespan and virion production rate
- Production of resistant HIV mutants during antiretroviral therapy
- Treatment interruptions and resistance: a review
- Understanding drug resistance for monotherapy treatment of HIV infection
Cited in
(60)- Study of HIV mathematical model under nonsingular kernel type derivative of fractional order
- The global dynamics in a wild-type and drug-resistant HIV infection model with saturated incidence
- Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects
- Two-way Bayesian hierarchical phylogenetic models: an application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment
- Dynamic analysis of a fractional-order model for HIV with drug-resistance and CTL immune response
- Modeling the effect of reactive oxygen species and CTL immune response on HIV dynamics
- Time-adaptive determination of drug efficacy in mathematical model of HIV infection
- Coupled within-host and between-host dynamics and evolution of virulence
- Application of fuzzy ABC fractional differential equations in infectious diseases
- Approximate analytical solution of a HIV/AIDS dynamic model during primary infection
- Stability analysis and numerical simulations of spatiotemporal HIV CD4+ T cell model with drug therapy
- Numerical solution with analysis of HIV/AIDS dynamics model with effect of fusion and cure rate
- Dynamics of an HIV model with multiple infection stages and treatment with different drug classes
- The threshold for a stochastic HIV-1 infection model with Beddington-DeAngelis incidence rate
- Analysis and optimal control of an HIV model with logistic growth and infected cells in eclipse phase
- Structure preserving numerical analysis of HIV and CD4+T-cells reaction diffusion model in two space dimensions
- Drug resistance in acute viral infections: rhinovirus as a case study
- A discrete-time analog for coupled within-host and between-host dynamics in environmentally driven infectious disease
- Analysis of a fractional model for HIV CD\(4^+\) T-cells with treatment under generalized Caputo fractional derivative
- Global dynamics for a drug-sensitive and drug-resistant mixed strains of HIV infection model with saturated incidence and distributed delays
- The modeling dynamics of HIV and CD4\(^{+}\) T-cells during primary infection in fractional order: numerical simulation
- An HIV infection model based on a vectored immunoprophylaxis experiment
- Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: parameter estimates, identifiability, sensitivity and the eclipse phase profile
- On the well-posedness of a fractional model of HIV infection
- Modeling HIV persistence, the latent reservoir, and viral blips
- Optimal therapy strategies for a free boundary parabolic-hyperbolic HIV infection model with antiretroviral drugs application
- A mathematical model for transmission dynamics of HIV/AIDS with effect of weak CD4^+ T cells
- Stability of a CD\(4^+\) T cell viral infection model with diffusion
- Global dynamics of an age-structured model for HIV viral dynamics with latently infected T cells
- Global stability for an HIV-1 infection model including an eclipse stage of infected cells
- Stability and bifurcation analysis of a fractional‐order model of cell‐to‐cell spread of HIV‐1 with a discrete time delay
- Modeling within-host viral dynamics: the role of CTL immune responses in the evolution of drug resistance
- Modeling and stability analysis of HIV-1 as a time delay fuzzy T-S system via LMIs
- Immune response in virus model structured by cell infection-age
- Analysis of a CD4\(^+\) T cell viral infection model with a class of saturated infection rate
- A fractional-order model of HIV infection with drug therapy effect
- A new method for solving fuzzy Bernoulli differential equation
- Complete classification of global dynamics of a virus model with immune responses
- Global dynamics for viral infection model with Beddington-Deangelis functional response and an eclipse stage of infected cells
- Emerging disease dynamics in a model coupling within-host and between-host systems
- Stability and bifurcation analysis of an HIV-1 infection model with a general incidence and CTL immune response
- Mathematical modeling of viral infection dynamics in spherical organs
- The effect of delay in viral production in within-host models during early infection
- Vectored immunoprophylaxis and cell-to-cell transmission in HIV dynamics
- Modeling within-host evolution of HIV: mutation, competition and strain replacement
- Global stability of a fractional order HIV infection model with cure of infected cells in eclipse stage
- Optimizing within-host viral fitness: infected cell lifespan and virion production rate
- A within-host drug resistance model with continuous state-dependent viral strains
- Accounting for multi-delay effects in an HIV-1 infection model with saturated infection rate, recovery and proliferation of host cells
- A delay-dependent model with HIV drug resistance during therapy
- Modeling the dynamics of HIV and \(CD4^{+}\)T cells during primary infection
- Stationary distribution and extinction of a stochastic HLIV model with viral production and Ornstein-Uhlenbeck process
- Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection
- Stability and Hopf bifurcation of HIV-1 model with Holling II infection rate and immune delay
- Investigation of fractal-fractional HIV infection by evaluating the drug therapy effect in the Atangana-Baleanu sense
- Spatio-temporal modeling and analysis of two HIV strain infections via demographic-geographic data
- The influence of anti-viral drug therapy on the evolution of HIV-1 pathogens
- Global dynamics of a delay virus model with recruitment and saturation effects of immune responses
- On the approximate solution of dynamic systems derived from the HIV infection of CD\(_4^+\) T cells using the LRBF-collocation scheme
- Spatiotemporal dynamics of an HIV infection model with delay in immune response activation
This page was built for publication: Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2219787)
